- Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
- Tectonic Therapeutic to Participate in March Investor Conferences
- Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference
- Aeries Technology, Inc. Announces $5.0 Million Share Repurchase Authorization
- StepStone Real Estate Awarded Global Indirect Firm of the Year and European Deal of the Year in PERE 2025 Awards
- Uniti Group Inc. Reports Fourth Quarter and Full Year 2025 Results
- XRP price drops below $1.61 – 2 factors for the bulls avoid $1.10
- Data: Hyperliquid platform whale currently holds $2.887 billions, with a long-short ratio of 0.99
- Bitget adds stock contracts for TSMC TSM, Walmart WMT, Costco COST, and others
- Tokenized gold PAXG, XAUT jump as missiles fly, BTC stalls near $66.2k
- Sanae Takashi issues statement on "SANAE TOKEN": unrelated and unauthorized
- Q1 2026 Shocker: IPO Genie ($IPO) Crushes BlockDAG & Nexchain to Claim #1 Spot in AI Crypto Presales
- Caixin Futures: Middle East tensions boost risk aversion, non-ferrous and precious metals sectors generally fluctuate with a strong bias
- Spanish Prime Minister: Amazon will invest 18 billion euros in Spain, marking its largest investment outside the United States.
- UK interest rate futures indicate about 40 basis points of rate cuts by the end of 2026
- Decentralized contract trading platform Sun Wukong launches USOIL perpetual contracts
- Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.085 per Share for March 2026
- SL Green Promotes Harrison Sitomer to President and Chief Investment Officer
- Morgan Stanley strategist Wilson: The Iran situation is unlikely to shake the bullish outlook on US stocks
- JPMorgan optimistic about buying opportunities during stock market pullbacks; oil price premium unlikely to last
- Qatar Energy halts LNG production after attack, European gas prices surge 50%! Goldman Sachs: If blockade continues, prices could double
- XRP Long Traders in Loss Amid $358 Million in Combined Crypto Liquidations
- Shiba Inu (SHIB) Price Reset Point: Three Oversold Indicators, 20% Potential
- Best Crypto Presale Presale 2026: Pepeto Might Shock Traders This Year as SEC Task Force Reshapes Crypto Rules, DeepSnitch AI and IPO Genie Trail Behind
- S.Korea’s Tax Agency Leaked Crypto Master Key — and Got Robbed Twice
- Inflation trades make a comeback as eurozone short-term government bond yields rebound sharply
- Investment institution Raymond James recently announced the initiation of coverage on US furniture retailer Bob’s Discount Furniture, Inc., assigning an “Outperform” rating.
- Tesla's new car registrations in Spain increased by 73.7% year-on-year in February
- Curve Finance investigates sDOLA LlamaLend attack incident
- AAON's (NASDAQ:AAON) Q4 CY2025 Sales Beat Estimates
- Can SUI Reclaim the $1 Target and Revive Fading Bullish Momentum?
- In February 2026, the crypto sector lost $26.5 million due to hacker attacks.
- According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), if the transaction between AES Corp and the Global Infrastructure Partners (GIP) consortium is terminated under certain circumstances, the GIP consortium will be required to pay AES Corp a termination fee.
- Major Development in Quantum Computing: BTQ Technologies Officially Added to WisdomTree Quantum Computing Fund (Ticker: WQTM) Portfolio
- Eton Pharmaceuticals, Inc. announced that, in addition to the acquisition of core assets, the company also plans to purchase approximately $1.5 million worth of inventory products at the time of transaction closing.
- Eton Pharmaceuticals, Inc. has signed a licensing agreement to successfully acquire the exclusive U.S. marketing rights for Hemangeol oral solution from Pierre Fabre Medicament Sas.
- While actively promoting a stock buyback program to narrow the net asset value discount, ProCap Financial recently completed a strategic acquisition of 450 bitcoins.
- Novocure Limited (NASDAQ: NVCR) recently announced that its innovative product Optune Lua® has received reimbursement approval from Japanese regulators for the treatment of non-small cell lung cancer (NSCLC).
- Biotechnology company Intellia Therapeutics announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on its Phase 3 Magnitude trial for transthyretin amyloid cardiomyopathy (ATTR-CM).
- According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), healthcare giant Humana stated that its GAAP-based earnings per share (EPS) guidance for fiscal year 2026 may be adjusted due to the company's ongoing value creation plan and other strategic initiatives.
- ProCap Financial adds 450 more bitcoin to its holdings
- Battered bitcoin could find solace in war-led 'debasement' trade
- 126,000,000,000 Shiba Inu Suddenly Hits Exchanges, but Bulls Stepped In Immediately
- “No Pain, No Gain,” Analyst Says XRP Drop to “Death Zone” Will Offer Opportunity of a Lifetime
- Key Cardano Wyckoff Events and Price Targets
- Bitcoin Cash dips 22% over one week while new lending protocol captures over 19,000 investor interest
- Bitcoin Cash dips 22% over one week while new lending protocol captures over 19,000 investor interest
- Obtaining accurate guidance − a talk by Alan Taylor
- Hunter: Latest Adjustments to the Dual Mandate and Steering Toward the Target
- A shock in the Middle East sends the US dollar and gold into turmoil! US bonds hit an 11-month low — beware of a reversal tonight
- Wrap and WOFT Establish Drone Test & Non-Lethal Response Training Site in Florida
- Trevi Therapeutics to Participate in Upcoming March Conferences
- Elemental Royalty Announces Amended and Upsized Credit Facility to up to US$200M
- Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis
- Nexxen Announces February 2026 Share Repurchase Program Summary
- Trevi Therapeutics to Participate in Upcoming March Conferences
- BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets
- Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Xanadu and Crane Harbor Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement
- Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
- Seabridge Gold Announces Results from Metallurgical Test Program at Snip North
- SL Green and Jeff Sutton Sell 690 Madison Avenue
- Altimmune to Participate in Upcoming Investor Conferences
- Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
- Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
- USD/JPY: Downward pressure seen easing in March – MUFG
- Bitcoin exposes the structural weaknesses that banks refuse to admit
- EasyA Co-Founder: This Event Will Be an Inflection Point for XRP If It Happens
- Stan Druckenmiller Says He 'Screwed It Up' With His Nvidia Holdings After Seeing 'Disturbingly Heated' Signals In Tech
- Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL (propranolol hydrochloride) Oral Solution
- CMT-Certified Expert Flags Bitcoin Buy Signal, Is It Time To Go All In On BTC?
- Swiss franc drops sharply following earlier SNB caution
- 特朗普胜选黄金遭遇滑铁卢，现货金价已较高位暴跌逾230美元
- Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments
- Turkey's ruling party proposes a 10% tax on crypto income and a 0.03% transaction tax for service providers
- Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone
- Crypto funds snap outflow streak with $1bn inflows amid Middle East strikes
- USD: BBH Highlights Data and Risk Aversion Trends
- Brazil-listed BTC treasury company OranjeBTC holds a total of 3,723 BTC, with a total investment of approximately $392.34 millions.
- Bitcoin Price News: BTC Drops While DeepSnitch AI Surges 175% In Presale
- US short-term CPI swaps surge sharply, 1-year contract rises to 2.62%
- The number of active retail users on Hyperliquid has increased significantly, with a preference for high-leverage trading.
- The U.S. Defense Logistics Agency and Terves LLC, a subsidiary of Realloys, have reached a groundbreaking partnership and signed a milestone supply contract.
- Fidelis Insurance Group has officially announced that it will repurchase all remaining common shares held by CVC Falcon Holdings Limited.
- Bank of America Global Research recently announced the official initiation of research coverage on biotechnology company Eikon Therapeutics (stock code: EIKN), and assigned an initial "Buy" rating.
- ADMA Biologics (NASDAQ: ADMA) recently announced a $125 million accelerated share repurchase agreement with JPMorgan.
- JPMorgan: If passage through the Strait of Hormuz is blocked for 3-4 weeks, crude oil prices could be pushed above $100 per barrel
- HudBay Minerals Inc (stock code: HBM) announced it will acquire Arizona Sonoran for $1.48 billions. Following this news, its US-listed shares fell 1.8% in pre-market trading.
- ADT Inc. recently announced its updated multi-year financial framework, clarifying the company's future growth targets.
- M2 money supply is surging again – so why isn’t this bullish for Bitcoin anymore?
- Building the Backbone: Institutional Leaders on Crypto’s Infrastructure at Liquidity Summit 2026
- Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa
- Pundit to XRP Investors: It’s Happening, Just As We Have Been Waiting for. Here’s the Latest
- NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference
- NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer
- uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease
- Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results
- Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
- Anfield Energy Announces Shareholder Approval at Special Shareholder Meeting of Uranium Energy Corp. as a Control Person
- Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
